Author： Gordon G. Liu Jeff J. Guo Scott R. Smith
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.22, Iss.18, 2004-01, pp. : 1181-1194
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Modelling outcomes and costs of HIV/AIDS therapy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 360, 2002-01 ,pp. :
Access to resources
Recommend
Indirect costs of HIV/AIDS substantial in Spain
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 433, 2003-01 ,pp. :
Indirect Costs in Ambulatory Patients with HIV/AIDS in Spain: A Pilot Study
PharmacoEconomics, Vol. 21, Iss. 15, 2003-01 ,pp. :
HAART accounts for large increase in HIV/AIDS costs in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 429, 2003-01 ,pp. :
HAART accounts for large increase in HIV/AIDS costs in Canada
Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. :